Connection

John Wrangle to Xenograft Model Antitumor Assays

This is a "connection" page, showing publications John Wrangle has written about Xenograft Model Antitumor Assays.
  1. SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors. Sci Adv. 2019 09; 5(9):eaax6352.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.